Esterina DAsti
Overview
Explore the profile of Esterina DAsti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
712
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tawil N, Chennakrishnaiah S, Bassawon R, Johnson R, DAsti E, Rak J
Thromb Res
. 2018 Apr;
164 Suppl 1:S136-S142.
PMID: 29703472
Molecular profiling of human cancers revealed a startling diversity in disease-causing mechanisms superseding histological and anatomical commonalities. The emerging molecular subtypes and disease entities are often driven by distinct oncogenic...
2.
DAsti E, Anderson G, Rak J
Biochem Biophys Res Commun
. 2017 Nov;
494(3-4):700-705.
PMID: 29111325
Tissue factor (TF) is a transmembrane receptor for coagulation factor VII/VIIa and is frequently overexpressed by cancer cells. The TF/VIIa complex acts as the main initiator of the clotting cascade...
3.
Choi D, Lee T, Spinelli C, Chennakrishnaiah S, DAsti E, Rak J
Semin Cell Dev Biol
. 2017 Jan;
67:11-22.
PMID: 28077296
Pathogenesis of human cancers bridges intracellular oncogenic driver events and their impact on intercellular communication. Among multiple mediators of this 'pathological connectivity' the role of extracellular vesicles (EVs) and their...
4.
DAsti E, Meehan B, Rak J
Methods Mol Biol
. 2016 Sep;
1458:39-58.
PMID: 27581013
Angiogenesis represents one aspect in the complex process that leads to the generation of the vascular tumor stroma. The related functional constituents include responses of endothelial, mural, bone marrow-derived, and...
5.
Lee T, Chennakrishnaiah S, Meehan B, Montermini L, Garnier D, DAsti E, et al.
Oncotarget
. 2016 Jul;
7(32):51991-52002.
PMID: 27437771
Extracellular vesicles (EVs) enable the exit of regulatory, mutant and oncogenic macromolecules (proteins, RNA and DNA) from their parental tumor cells and uptake of this material by unrelated cellular populations....
6.
DAsti E, Rak J
Thromb Res
. 2016 Apr;
140 Suppl 1:S37-43.
PMID: 27067976
Activation of stromal response pathways in cancer is increasingly viewed as both a local and systemic extension of molecular alterations driving malignant transformation. Rather than reflecting passive and unspecific responses...
7.
DAsti E, Chennakrishnaiah S, Lee T, Rak J
Cell Mol Neurobiol
. 2016 Mar;
36(3):383-407.
PMID: 26993504
Brain tumors can be viewed as multicellular 'ecosystems' with increasingly recognized cellular complexity and systemic impact. While the emerging diversity of malignant disease entities affecting brain tissues is often described...
8.
DAsti E, Huang A, Kool M, Meehan B, Chan J, Jabado N, et al.
Am J Pathol
. 2015 Dec;
186(2):446-59.
PMID: 26687818
Pediatric embryonal brain tumors with multilayered rosettes demonstrate a unique oncogenic amplification of the chromosome 19 miRNA cluster, C19MC. Because oncogenic lesions often cause deregulation of vascular effectors, including procoagulant...
9.
Fang Y, Garnier D, Lee T, DAsti E, Montermini L, Meehan B, et al.
Angiogenesis
. 2015 Sep;
19(1):25-38.
PMID: 26374632
Oncogenic transformation is believed to impact the vascular phenotype and microenvironment in cancer, at least in part, through mechanisms involving extracellular vesicles (EVs). We explored these questions in the context...
10.
DAsti E, Fang Y, Rak J
Rambam Maimonides Med J
. 2014 Nov;
5(4):e0030.
PMID: 25386346
The coagulation system constitutes an important facet of the unique vascular microenvironment in which primary and metastatic brain tumors evolve and progress. While brain tumor cells express tissue factor (TF)...